DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Bouillon K, Bertrand M, Maura G, Blotière PO, Ricordeau P, Zureik M.
Risk of bleeding and arterial thromboembolism in patients with non-valvular atrial fibrillation either maintained on a vitamin K antagonist or switched to a non-vitamin K-antagonist oral anticoagulant: a retrospective, matched-cohort study.
Lancet Haematol 2015;
2 (04) e150-e159
We do not assume any responsibility for the contents of the web pages of other providers.